Akebia Therapeutics, Inc. (AKBA)

1.615 -0.04 (-2.71%) USD  |  NASDAQ  |  Dec 15, 16:00
1.615 0.00 (0.00%) After-Hours: 20:00
More

Akebia Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade